Comment on ‘Cefiderocol, a New Siderophore Cephalosporin for the Treatment of Complicated Urinary Tract Infections Caused by Multidrug-resistant Pathogens: Preclinical and Clinical Pharmacokinetics, Pharmacodynamics, Efficacy and Safety’

Detalles Bibliográficos
Autores principales: Koren, Andrew, Karas, Andreas, Echols, Roger
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8245373/
https://www.ncbi.nlm.nih.gov/pubmed/34037974
http://dx.doi.org/10.1007/s40261-021-01043-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8245373/
https://www.ncbi.nlm.nih.gov/pubmed/34037974
http://dx.doi.org/10.1007/s40261-021-01043-4

Ejemplares similares